durapatite has been researched along with Bone Neoplasms in 112 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (0.89) | 18.7374 |
| 1990's | 15 (13.39) | 18.2507 |
| 2000's | 18 (16.07) | 29.6817 |
| 2010's | 60 (53.57) | 24.3611 |
| 2020's | 18 (16.07) | 2.80 |
| Authors | Studies |
|---|---|
| Dai, HL; Li, ZH; Meng, ZY; Wang, YC; Xiao, Y; Zhao, Z | 1 |
| Abudayeh, A; Drobotun, OV; Konovalenko, VF; Protsenko, VV; Solonitsyn, EO; Ternovyi, NK; Tuz, EV; Ulianchych, NV | 1 |
| Aizawa, T; Hitachi, S; Iwatsu, J; Watanabe, M; Watanuki, M; Yoshida, S | 1 |
| Chen, S; Hua, Y; Li, X; Liu, S; Tu, C; Wu, H; Yang, X; Zeng, Q; Zhang, X; Zhou, Y; Zhu, X | 1 |
| Chen, X; Hao, S; Song, J; Wang, Y; Yu, S; Zhai, D; Zhou, J | 1 |
| Du, C; Wan, Y; Wang, Y; Xie, Z; Xu, D | 1 |
| Bai, D; Chen, W; Dai, W; Deng, Y; Li, B; Li, Y; Shu, R; Yang, F; Zheng, Y | 1 |
| Kaewsrichan, J; Thepsri, N | 1 |
| Bose, S; Kushram, P; Majumdar, U | 1 |
| Boccaccini, AR; Ciraldo, FE; Cresswell, M; Gritsch, L; Jackson, PR; Lovell, C; Maqbool, M; Mouriño, V | 1 |
| Cheng, KY; Hongsmatip, P; Kim, C; Lawrence, DA; Rivera, R; Smitaman, E | 1 |
| Chen, F; He, SS; Jiang, YY; Liu, JJ; Qin, YH; Sun, TW; Wu, J; Zhang, Y; Zhou, ZF; Zhu, YJ | 1 |
| Bose, S; Koski, C; Vu, AA | 1 |
| Chen, D; Li, G; Liu, W; Niu, X; Sun, Y; Tian, W; Wan, B; Wang, Q; Wang, R | 1 |
| Kamble, S; Müllner, M; Pelras, T; Rohanizadeh, R; Varamini, P | 1 |
| Kishi, K; Kono, M; Miwa, T; Sakamoto, Y; Yoshida, K | 1 |
| Ahmed, WA; Elfeky, SA; Elsayed, A; Moawad, M | 1 |
| Demiya, K; Fujiwara, T; Hasei, J; Kunisada, T; Nakata, E; Ozaki, T; Yokoo, S | 1 |
| Adamiano, A; Barbanente, A; Ditaranto, N; Esposti, LD; Gervaso, F; Iafisco, M; Ivanchenko, P; Leeuwenburgh, S; Margiotta, N; Migoni, D; Nadar, R; Palazzo, B | 1 |
| Deng, Y; Feng, P; Gao, C; Liu, C; Liu, Q; Shuai, C; Tan, W; Wang, Z | 1 |
| Engellau, J; Isaksson, H; Lidgren, L; Liu, Y; Nagesh, H; Raina, DB; Sebastian, S; Tägil, M | 1 |
| Chakraborty, S; Chakravarty, R; Dash, A; Kamaleshwaran, K; Radhakrishnan, E; Rajeswari, A; Sarma, HD; Shinto, AS; Vimalnath, KV | 1 |
| Mickens, J; Uskoković, V; Wu, VM | 1 |
| Ginalska, G; Kolmas, J; Oledzka, E; Pajchel, L; Pajor, K; Przekora, A; Sobczak, M | 1 |
| Bortel, EL; Chiou, AE; Duda, GN; Estroff, LA; Fischbach, C; Fratzl, P; He, F; Hoerth, R; Lee, MJ; Loh, HC; Lynch, M; Masic, A; Seo, BR; Song, YH; Wagermaier, W; Willie, BM | 1 |
| Barros, ALB; E Silva, ATM; Fernandes, C; Ferreira Soares, DC; Ferreira, CA; Maia, ALC; Oliveira, DCP; Ramaldes, GA; Silva Cunha Júnior, AD | 1 |
| Hibino, N; Isobe, Y; Katsumi, H; Naito, C; Tanaka, Y; Yagi, Y; Yamada, S; Yamamoto, A; Yamashita, S | 1 |
| Jayakrishnan, A; Kumar, TSS; Prasad, SR | 1 |
| Matsuda, S; Okamoto, T; Sakamoto, A | 1 |
| Bahrami-Samani, A; Ghannadi-Maragheh, M; Salek, N; Shirvani-Arani, S; Vosoghi, S; Yousefi, A | 1 |
| Cai, X; Chen, H; Cheng, Y; He, X; Huang, Q; Li, Y; Lin, K; Wang, Y; Xiao, J; Zhang, Q; Zou, Y | 1 |
| Bischoff, I; Chai, F; Fürst, R; Kirkpatrick, CJ; Tsaryk, R; Unger, RE | 1 |
| D'Acunto, M; D'Alessandro, D; Danti, S; Trombi, L | 1 |
| Burton, LJ; Campbell, T; Dougan, J; Hawsawi, O; Henderson, VM; Howard, SM; Odero-Marah, VA; Trice, K | 1 |
| Adamiano, A; Canepa, F; Carella, F; Iafisco, M; Lamura, G; Tampieri, A; Uskoković, V; Wu, VM | 1 |
| Guo, Z; Hamilton, AR; Jiang, N; Li, Y; McCoy, CP; Moore, J; Rafferty, C; Sarri, G; Sun, D; Zhang, L; Zhu, S; Ziminska, M | 1 |
| Albu, MG; Andronescu, E; Cimpean, A; Ficai, A; Ficai, D; Ion, R; Mitran, V; Sonmez, M | 1 |
| Lee, JS; Tung, CH | 1 |
| Aston, WJ; Batta, V; Blunn, GW; Briggs, TW; Cannon, SR; Coathup, MJ; Pollock, RC; Skinner, JA; Unwin, PS | 1 |
| Abdelkarim, M; Blanchemain, N; Chai, F; Degoutin, S; Hildebrand, HF; Laurent, T; Martel, B; Peters, F; Simon, N; Tabary, N | 1 |
| Abarrategi, A; Astudillo, A; Colmenero, I; Garcia-Castro, J; Martinez-Cruzado, L; Menendez, P; Mulero, F; Rodriguez, R; Rosu-Myles, M; Rubio, R; Santos, L; Suarez, C; Tornin, J | 1 |
| Duan, H; Lang, Y; Li, H; Min, L; Mo, A; Pei, F; Ren, C; Tu, C; Xiong, Y; Yan, Y; Yang, H; Zhang, B; Zhang, W | 1 |
| Chen, J; Duan, L; Huang, J; Liu, J; Wang, D; Xiong, J; You, W; Zeng, Y; Zhu, W | 1 |
| Kopeček, J; Low, SA; Yang, J | 1 |
| Castro, NJ; Fu, SW; Fu, Y; Wang, M; Zhang, LG; Zhu, W | 1 |
| Aston, WJ; Blunn, GW; Briggs, TW; Cannon, SR; Coathup, MJ; Gikas, PD; Pollock, RC; Sanghrajka, A; Skinner, JA | 1 |
| Banerjee, S; Das, T | 1 |
| Chen, W; Guo, X; Liao, Y; Liu, H; Liu, X; Zhao, N | 1 |
| Chen, HF; Chiang, YH; Chiou, A; Kuo, YC; Lee, OK; Wu, SH | 1 |
| Hao, H; Li, Y; Liu, H; Ma, J; Mao, C; Wang, Y; Yang, G; Zhang, S | 1 |
| Sneha, M; Sundaram, NM | 1 |
| da Silva, FMR; de Almeida, JC; de Souza Albernaz, M; Oliveira, EEM; Rossi, AM; Santos-Oliveira, R | 1 |
| Chakraborty, S; Chakravarty, R; Dash, A; Nair, KV; Rajeswari, A; Ram, R; Sarma, HD | 1 |
| Belchior, A; Correia, JD; Fernandes, C; Gano, L; Marques, F; Monteiro, S; Santos, I | 1 |
| Cai, BT; Cao, YL; Rong, ZJ; Wu, GF; Yang, LJ; Zhang, ZJ; Zhu, LX | 1 |
| Ioku, K; Kamitakahara, M; Kawashita, M; Ohtoshi, N | 1 |
| Cunningham, D; Liu, S; Mei, J; Parajuli, KR; Wang, G; You, Z; Zhang, C; Zhang, Q | 1 |
| Jiang, L; Su, S; Xiong, C | 1 |
| Alves, RJ; Caravan, P; de Souza Filho, JD; Faria, SD; Ferreira, Ddos S; Ferreira, LA; Guimarães, AR; Lopes, SC; Magalhães-Paniago, R; Malachias, A; Oliveira, BL; Oliveira, MC; Teixeira, CS | 1 |
| Cai, M; Hao, H; Li, Y; Ma, J; Mao, C; Wang, J; Wang, S; Wang, Y; Zhang, S | 1 |
| Aryal, S; Nguyen, TD; Pitchaimani, A | 1 |
| Chu, W; Cui, S; Huang, Y; Liao, Y; Yan, M; Yang, C; Zhang, X; Zhao, C | 1 |
| Murase, T; Myoui, A; Tamai, N; Yoshikawa, H | 1 |
| Fischbach, C; Kowalczewski, C; Pathi, SP; Tadipatri, R | 1 |
| Fischer, J; Hernigou, P; Herten, M; Jäger, M; Krauspe, R; Zilkens, C | 1 |
| Andronescu, E; Ficai, A; Ficai, D; Ficai, M; Maganu, M; Voicu, G | 1 |
| Hattori, H; Matsuoka, H; Yamamoto, K | 1 |
| Kudawara, I; Myoui, A; Tamai, N; Ueda, T; Yoshikawa, H | 1 |
| Jiang, Y; Ou, J; Qin, QH; Zhang, Z | 1 |
| Dorvee, JR; Estroff, LA; Fischbach, C; Lin, DD; Pathi, SP | 1 |
| Jansen, JA; Kamphuis, GJ; Lopez-Heredia, MA; Öner, FC; Thüne, PC; Walboomers, XF | 1 |
| Aso, M; Ekimoto, H; Nakatake, H; Ogawa, A; Suemune, H; Yamaguchi, A | 1 |
| Kanbara, H; Kitamura, Y; Kiwada, T; Odani, A; Ogawa, K; Shiba, K; Takai, K | 1 |
| Ashino, H; Dozono, H; Hino, A; Kasahara, H; Minamizawa, T; Oshikiri, S; Satake, M; Suwada, J; Suzuki, K | 1 |
| Bausbacher, N; Biesalski, B; Fellner, M; Hermann, P; Kubícek, V; Rösch, F; Thews, O | 1 |
| Duan, H; Min, L; Pei, FX; Shi, R; Tu, CQ; Zhang, H; Zhang, SL; Zhou, Y | 1 |
| Iafisco, M; Margiotta, N | 1 |
| Abu Ajaj, K; Hochdörffer, K; Kratz, F; Schäfer-Obodozie, C | 1 |
| Guo, B; Hong, Y; Liu, M; Luo, H; Qing, F; Wang, Z; Zhang, X | 1 |
| Belquin-myrdycz, A; Descamps, M; Hildebrand, HF; Laffargue, P; Lefèvre, A; Monchau, F | 1 |
| Ni, M; Ratner, B; Zhang, M; Zhang, Y | 1 |
| Kim, YT; Ninomiya, S; Sekikawa, M; Tachibana, Y | 1 |
| KROKOWSKI, E | 1 |
| Araki, N; Kusuzaki, K; Matsumine, A; Myoui, A; Seto, M; Uchida, A; Yoshikawa, H | 1 |
| Bae, CJ; Kim, HE; Kim, HW; Kong, YM; Lee, SH | 1 |
| Kim, HE; Kim, HW; Knowles, JC; Salih, V | 1 |
| Honoki, K; Kotobuki, N; Matsushima, A; Morishita, T; Ohgushi, H; Takakura, Y | 1 |
| Fleming, J; Halpern, J; Hamming, D; Holt, GE; Lynch, CC; Martin, MD; Matrisian, LM; Schwartz, HS | 1 |
| Fujii, H; Honoki, K; Kawamura, K; Kido, A; Kobata, Y; Mii, Y; Miyauchi, Y; Morishita, T; Shigematu, K; Takakura, Y; Yajima, H | 1 |
| Blunn, GW; Briggs, TW; Cannon, SR; Schindler, OS | 2 |
| El-Mabhouh, AA; Mercer, JR | 1 |
| Iwata, H; Nabeshima, T; Osada, T; Yamamura, K; Yotsuyanagi, T | 1 |
| Flügel, M; Freiberger, N; Geldmacher, J; Schaller, P | 1 |
| Clifford, CJ; Downes, S; Klein, CP; Scotchford, C | 1 |
| Battista, JJ; Breen, SL | 1 |
| Itokazu, M; Kumazawa, S; Wada, E; Wenyi, Y | 1 |
| Abrams, J; Kessler, FB; Tadjalli, HE | 1 |
| Hallfeldt, K; Kessler, S; Mandelkow, H; Schweiberer, L; Stützle, H | 1 |
| Alferiev, IS; Breuer, E; Cohen, H; Ezra, A; Golomb, G; Hägele, G; Hoffman, A; Mönkkönen, J; Ornoy, A; Patlas, N; Pinto, T; Sagi, H; Seibel, MJ; Solomon, V; Stepensky, D | 1 |
| Protsenko, VV; Tolstopiatov, BA | 2 |
| Blunn, GW; Briggs, TW; Cannon, SR; Cobb, JP; Culligan, S; Unwin, PS; Walker, PS | 1 |
| Frebel, T; Joist, A; Joosten, U; Langer, M; Walter, M | 1 |
| Marui, T; Mizuno, K; Onga, T; Yamamoto, T | 1 |
| Dai, J; Keller, ET; Lin, DL; Morris, MD; Patel, AH; Rohn, E; Tarnowski, CP; Zhang, J | 1 |
| Baer, W; Carl, HD; Schaller, P | 1 |
| Araki, N; Ono, K; Shinto, Y; Uchida, A | 2 |
| Araki, N; Kurisaki, E; Ono, K; Shinto, Y; Uchida, A; Yoshikawa, H | 1 |
| Shinjo, K | 1 |
| Duwe, F; Heise, U; Osborn, JF | 1 |
4 review(s) available for durapatite and Bone Neoplasms
| Article | Year |
|---|---|
Calcium hydroxyapatite deposition disease: Imaging features and presentations mimicking other pathologies.
Topics: Adult; Bone Diseases; Bone Diseases, Infectious; Bone Neoplasms; Calcinosis; Diagnosis, Differential; Durapatite; Early Diagnosis; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Tomography, X-Ray Computed | 2019 |
Interconnected porous hydroxyapatite ceramics for bone tissue engineering.
Topics: Adult; Animals; Bone Morphogenetic Proteins; Bone Neoplasms; Bone Substitutes; Bone Transplantation; Cartilage; Ceramics; Child, Preschool; Clinical Trials as Topic; Durapatite; Female; Humans; Japan; Male; Mesenchymal Stem Cells; Middle Aged; Orthopedic Procedures; Rats; Tendons; Tissue Engineering | 2009 |
[Cell therapy in bone-healing disorders].
Topics: Adolescent; Bone Cysts; Bone Neoplasms; Bone Regeneration; Bone Transplantation; Cell Differentiation; Child; Chondroma; Combined Modality Therapy; Durapatite; Fracture Healing; Humans; Mesenchymal Stem Cell Transplantation; Osteoblasts; Tissue and Organ Harvesting | 2010 |
Silica xerogels and hydroxyapatite nanocrystals for the local delivery of platinum-bisphosphonate complexes in the treatment of bone tumors: a mini-review.
Topics: Antineoplastic Agents; Bone Neoplasms; Bone Substitutes; Coordination Complexes; Diphosphonates; Drug Delivery Systems; Durapatite; Humans; Nanoparticles; Platinum; Prodrugs; Silica Gel | 2012 |
108 other study(ies) available for durapatite and Bone Neoplasms
| Article | Year |
|---|---|
Mesoporous polydopamine-coated hydroxyapatite nano-composites for ROS-triggered nitric oxide-enhanced photothermal therapy of osteosarcoma.
Topics: Arginine; Bone Neoplasms; Catalysis; Cell Line, Tumor; Cell Survival; Durapatite; Humans; Indocyanine Green; Indoles; Infrared Rays; Nanocomposites; Nitric Oxide; Osteosarcoma; Phototherapy; Polymers; Porosity; Reactive Oxygen Species | 2021 |
Experimental substantiation of the use of hydroxyapatite - tricalcium phosphate bioceramics for replacing bone defects after tumor removal.
Topics: Animals; Biocompatible Materials; Bone Diseases; Bone Neoplasms; Bone Regeneration; Calcium Phosphates; Ceramics; Durapatite; Osteoblasts; Osteoclasts; Osteogenesis; Rats | 2021 |
Clinical outcome of porous hydroxyapatite/collagen graft on bone defects following curettage of bone tumors.
Topics: Bone Neoplasms; Bone Regeneration; Collagen; Curettage; Durapatite; Humans; Porosity | 2022 |
A Selective Reduction of Osteosarcoma by Mitochondrial Apoptosis Using Hydroxyapatite Nanoparticles.
Topics: Animals; Apoptosis; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Durapatite; Humans; Mice; Nanoparticles; Osteosarcoma; Rats | 2022 |
Design and evaluation of
Topics: Bone and Bones; Bone Neoplasms; Durapatite; Humans; Nanoparticles; Radiopharmaceuticals | 2023 |
Hierarchically Structured Hydroxyapatite Particles Facilitate the Enhanced Integration and Selective Anti-Tumor Effects of Amphiphilic Prodrug for Osteosarcoma Therapy.
Topics: Bone Neoplasms; Drug Delivery Systems; Durapatite; Humans; Osteosarcoma; Prodrugs | 2023 |
A 3D-printed orthopedic implant with dual-effect synergy based on MoS
Topics: Animals; Bone Neoplasms; Bone Regeneration; Durapatite; Ketones; Molybdenum; Nanoparticles; Osteogenesis; Polyethylene Glycols; Printing, Three-Dimensional; Rats; X-Ray Microtomography | 2023 |
Triple-layered scaffold containing cisplatin and curcumin applied for cancerous bone regeneration.
Topics: Animals; Bone Neoplasms; Bone Regeneration; Cisplatin; Curcumin; Drug Carriers; Durapatite; Polyesters; Tissue Scaffolds | 2023 |
Hydroxyapatite coated titanium with curcumin and epigallocatechin gallate for orthopedic and dental applications.
Topics: Anti-Bacterial Agents; Bone Neoplasms; Curcumin; Durapatite; Humans; Osteosarcoma; Titanium | 2023 |
Chitosan/hydroxyapatite composite bone tissue engineering scaffolds with dual and decoupled therapeutic ion delivery: copper and strontium.
Topics: Biocompatible Materials; Bone Neoplasms; Bone Regeneration; Cell Differentiation; Chitosan; Copper; Durapatite; Humans; Osteoblasts; Osteogenesis; Osteosarcoma; Strontium; Tissue Engineering; Tumor Cells, Cultured | 2019 |
Selenium-doped hydroxyapatite biopapers with an anti-bone tumor effect by inducing apoptosis.
Topics: Animals; Antineoplastic Agents; Apoptosis; Bone Neoplasms; Cell Line, Tumor; Durapatite; Humans; Membrane Potential, Mitochondrial; Mice; Nanowires; Paper; Selenium; Xenograft Model Antitumor Assays | 2019 |
Effects of chitosan-loaded hydroxyapatite on osteoblasts and osteosarcoma for chemopreventative applications.
Topics: Biocompatible Materials; Bone Neoplasms; Bone Regeneration; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cells, Cultured; Chitosan; Delayed-Action Preparations; Durapatite; Humans; Osteoblasts; Osteosarcoma; Tissue Scaffolds | 2020 |
Anti-osteosarcoma effect of hydroxyapatite nanoparticles both in vitro and in vivo by downregulating the FAK/PI3K/Akt signaling pathway.
Topics: Animals; Apoptosis; Bone Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Durapatite; Mice; Mice, Inbred BALB C; Nanoparticles; Osteosarcoma; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction | 2020 |
Bisphosphonate-functionalized micelles for targeted delivery of curcumin to metastatic bone cancer.
Topics: Alendronate; Antineoplastic Agents; Bone Neoplasms; Curcumin; Diphosphonates; Drug Carriers; Drug Delivery Systems; Drug Liberation; Durapatite; Micelles; Nanoparticles; Particle Size; Poloxamer; Polymers; Tumor Microenvironment | 2020 |
Exchange Cranioplasty Using Bioabsorbable Hydroxyapatite and Collagen Complex After Removal of an Extensive Frontal Bone Tumor in an Infant.
Topics: Autografts; Bone Neoplasms; Bone Substitutes; Bone Transplantation; Collagen; Craniotomy; Durapatite; Female; Forehead; Frontal Bone; Humans; Infant; Parietal Bone; Plastic Surgery Procedures; Sarcoma, Ewing | 2020 |
Hydroxyapatite nanocomposite as a potential agent in osteosarcoma PDT.
Topics: Animals; Bone Neoplasms; Cell Line, Tumor; Durapatite; Humans; Mice; Nanocomposites; Osteosarcoma; Photochemotherapy; Photosensitizing Agents | 2020 |
Radiographic and clinical assessment of unidirectional porous hydroxyapatite to treat benign bone tumors.
Topics: Adolescent; Bone Neoplasms; Bone Substitutes; Bone Transplantation; Child; Durapatite; Female; Femur; Humans; Male; Retrospective Studies; Treatment Outcome; Wound Healing; X-Ray Microtomography | 2020 |
Selenium-doped hydroxyapatite nanoparticles for potential application in bone tumor therapy.
Topics: Antineoplastic Agents; Bone Neoplasms; Cell Survival; Durapatite; Humans; Microscopy, Electron, Transmission; Nanoparticles; PC-3 Cells; Selenium; Selenium Oxides; X-Ray Diffraction | 2021 |
Dual-functional scaffolds of poly(L-lactic acid)/nanohydroxyapatite encapsulated with metformin: Simultaneous enhancement of bone repair and bone tumor inhibition.
Topics: Bone Neoplasms; Durapatite; Humans; Lactic Acid; Metformin; Osteogenesis; Polyesters; Tissue Engineering; Tissue Scaffolds | 2021 |
Sustained and controlled delivery of doxorubicin from an in-situ setting biphasic hydroxyapatite carrier for local treatment of a highly proliferative human osteosarcoma.
Topics: Bone Neoplasms; Cell Line, Tumor; Doxorubicin; Drug Delivery Systems; Durapatite; Humans; Osteosarcoma | 2021 |
A "mix-and-use" approach for formulation of human clinical doses of
Topics: Animals; Bone Neoplasms; Cancer Pain; Durapatite; Humans; Lutetium; Male; Organophosphorus Compounds; Pharmacy Service, Hospital; Radioisotopes; Rats; Tissue Distribution | 2017 |
Bisphosphonate-Functionalized Hydroxyapatite Nanoparticles for the Delivery of the Bromodomain Inhibitor JQ1 in the Treatment of Osteosarcoma.
Topics: Bone Neoplasms; Cell Line, Tumor; Diphosphonates; Durapatite; Humans; Nanoparticles; Osteosarcoma | 2017 |
Fabrication and physicochemical characterization of porous composite microgranules with selenium oxyanions and risedronate sodium for potential applications in bone tumors.
Topics: Alginates; Anions; Antineoplastic Agents; Bone Neoplasms; Cell Line, Tumor; Drug Carriers; Durapatite; Glucuronic Acid; Hexuronic Acids; Humans; Magnetic Resonance Spectroscopy; Microscopy, Electron, Transmission; Nanoparticles; Osteosarcoma; Porosity; Powders; Risedronic Acid; Selenium; Spectroscopy, Fourier Transform Infrared; X-Ray Diffraction | 2017 |
Multiscale characterization of the mineral phase at skeletal sites of breast cancer metastasis.
Topics: Animals; Bone Density; Bone Neoplasms; Breast Neoplasms; Cell Line, Tumor; Durapatite; Female; Heterografts; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Neoplasm Metastasis; Neoplasm Transplantation; Tibia; X-Ray Microtomography | 2017 |
Vincristine-loaded hydroxyapatite nanoparticles as a potential delivery system for bone cancer therapy.
Topics: Antineoplastic Agents, Phytogenic; Bone Neoplasms; Cell Line, Tumor; Drug Delivery Systems; Durapatite; Humans; Nanoparticles; Tissue Distribution; Vincristine | 2018 |
Development of PEGylated aspartic acid-modified liposome as a bone-targeting carrier for the delivery of paclitaxel and treatment of bone metastasis.
Topics: Animals; Apoptosis; Aspartic Acid; Bone and Bones; Bone Neoplasms; Cell Line, Tumor; Drug Delivery Systems; Durapatite; Female; Flow Cytometry; Fluorescent Dyes; Liposomes; Male; Mice, Inbred C57BL; Osteoclasts; Paclitaxel; Polyethylene Glycols; Time Factors; Tissue Distribution; Tritium | 2018 |
Ceramic core with polymer corona hybrid nanocarrier for the treatment of osteosarcoma with co-delivery of protein and anti-cancer drug.
Topics: Animals; Antineoplastic Agents; Bone Neoplasms; Cattle; Cell Line, Tumor; Drug Carriers; Drug Delivery Systems; Drug Liberation; Durapatite; Methotrexate; Nanoparticles; Osteosarcoma; Polyvinyl Alcohol; Serum Albumin, Bovine | 2018 |
Unsintered Hydroxyapatite and Poly-L-Lactide Composite Screws/Plates for Stabilizing β-Tricalcium Phosphate Bone Implants.
Topics: Adolescent; Adult; Bone Neoplasms; Bone Substitutes; Calcium Phosphates; Cohort Studies; Durapatite; Female; Femur; Humans; Male; Middle Aged; Orthopedic Procedures; Plastic Surgery Procedures; Polyesters; Tibia; Young Adult | 2018 |
Highly Stable 177Lu-Organic Framework as a Potential Agent for Treatment of Metastatic Bone.
Topics: Animals; Antineoplastic Agents; Bone Neoplasms; Durapatite; Metal Nanoparticles; Metal-Organic Frameworks; Organometallic Compounds; Rats; Tissue Distribution | 2018 |
Multifunctional melanin-like nanoparticles for bone-targeted chemo-photothermal therapy of malignant bone tumors and osteolysis.
Topics: Alendronate; Animals; Antineoplastic Agents; Bone and Bones; Bone Neoplasms; Cells, Cultured; Combined Modality Therapy; Durapatite; Heterografts; Hyperthermia, Induced; Indoles; Infrared Rays; Irinotecan; Melanins; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Osteolysis; Phototherapy; Polymers; Tissue Distribution | 2018 |
In vitro evaluation of a biomaterial-based anticancer drug delivery system as an alternative to conventional post-surgery bone cancer treatment.
Topics: Antibiotics, Antineoplastic; Bone Neoplasms; Cyclodextrins; Doxorubicin; Drug Delivery Systems; Drug Screening Assays, Antitumor; Durapatite; Human Umbilical Vein Endothelial Cells; Humans; Osteoblasts; Osteosarcoma; Postoperative Care | 2018 |
Raman spectroscopy of osteosarcoma cells.
Topics: Bone Neoplasms; Cell Line, Tumor; Cells, Cultured; Durapatite; Gold; Humans; Interleukin-6; Mesenchymal Stem Cells; Metal Nanoparticles; Osteoblasts; Osteosarcoma; Spectrum Analysis, Raman | 2018 |
Cancer-bone microenvironmental interactions promotes STAT3 signaling.
Topics: Animals; Bone and Bones; Bone Neoplasms; Calcium; Cathepsin L; Cell Line, Tumor; Cell Movement; Cell Proliferation; Durapatite; Egtazic Acid; HEK293 Cells; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Phosphorylation; Prostatic Neoplasms; Pyridines; RNA Interference; RNA, Small Interfering; Signal Transduction; Snail Family Transcription Factors; STAT3 Transcription Factor; Tumor Microenvironment; Tyrphostins | 2019 |
Magnetic calcium phosphates nanocomposites for the intracellular hyperthermia of cancers of bone and brain.
Topics: Animals; Anti-Bacterial Agents; Bone Neoplasms; Brain Neoplasms; Calcium Phosphates; Cell Line, Tumor; Cell Survival; Durapatite; Fibroblasts; Humans; Hyperthermia, Induced; Iron; Magnetic Fields; Magnetite Nanoparticles; Nanocomposites | 2019 |
Nanoscale Hybrid Coating Enables Multifunctional Tissue Scaffold for Potential Multimodal Therapeutic Applications.
Topics: Bone Neoplasms; Chitosan; Coated Materials, Biocompatible; Drug Liberation; Durapatite; Graphite; Humans; Hydrogen-Ion Concentration; Phototherapy; Porosity; Tissue Engineering; Tissue Scaffolds | 2019 |
Collagen-hydroxyapatite/cisplatin drug delivery systems for locoregional treatment of bone cancer.
Topics: Antineoplastic Agents; Bone Neoplasms; Cell Line, Tumor; Cisplatin; Collagen; Drug Delivery Systems; Durapatite; Humans; Porosity; Proliferating Cell Nuclear Antigen; Spectrophotometry, Infrared; X-Ray Diffraction | 2013 |
Osteotropic cancer diagnosis by an osteocalcin inspired molecular imaging mimetic.
Topics: Bone Neoplasms; Cell Line, Tumor; Durapatite; Fluorescein-5-isothiocyanate; Humans; Molecular Mimicry; Osteocalcin; Osteosarcoma; Tissue Array Analysis | 2013 |
Long-term survival of cemented distal femoral endoprostheses with a hydroxyapatite-coated collar: a histological study and a radiographic follow-up.
Topics: Adolescent; Adult; Aged; Bone Neoplasms; Coated Materials, Biocompatible; Durapatite; Female; Femur; Follow-Up Studies; Humans; Male; Middle Aged; Osseointegration; Prostheses and Implants; Prosthesis Implantation; Radiography; Treatment Outcome | 2013 |
Poly-cyclodextrin functionalized porous bioceramics for local chemotherapy and anticancer bone reconstruction.
Topics: Animals; Bone Neoplasms; Bone Substitutes; Cell Line; Ceramics; Cyclodextrins; Drug Delivery Systems; Durapatite; Materials Testing; Mice; Osteoblasts; Polymers; Porosity; Tissue Scaffolds | 2014 |
Bone environment is essential for osteosarcoma development from transformed mesenchymal stem cells.
Topics: Animals; Blotting, Western; Bone and Bones; Bone Morphogenetic Protein 2; Bone Neoplasms; Calcium Phosphates; Cell Line, Tumor; Cell Transformation, Neoplastic; Cells, Cultured; Cellular Microenvironment; Ceramics; Durapatite; Humans; Interleukin Receptor Common gamma Subunit; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Mice, Inbred NOD; Mice, Knockout; Mice, SCID; Osteogenesis; Osteosarcoma; Retinoblastoma Protein; Reverse Transcriptase Polymerase Chain Reaction; Tissue Scaffolds; Tumor Suppressor Protein p53 | 2014 |
Analyzing the behavior of a porous nano-hydroxyapatite/polyamide 66 (n-HA/PA66) composite for healing of bone defects.
Topics: Adolescent; Adult; Animals; Bone Diseases; Bone Neoplasms; Bone Substitutes; Bone Transplantation; Durapatite; Female; Humans; Male; Materials Testing; Middle Aged; Nanocomposites; Nanomedicine; Nylons; Osseointegration; Porosity; Rabbits; Radiography; Retrospective Studies; Young Adult | 2014 |
Study on clinical application of nano-hydroxyapatite bone in bone defect repair.
Topics: Adolescent; Adult; Aged; Bone Neoplasms; Bone Substitutes; Calcaneus; Child; Durapatite; Female; Femur; Fractures, Bone; Humans; Humerus; Male; Middle Aged; Nanostructures; Radiography; Radius; Tibia; Tissue Engineering; Ulna; Wound Healing | 2015 |
Bone-targeted acid-sensitive doxorubicin conjugate micelles as potential osteosarcoma therapeutics.
Topics: Amino Acids; Aspartic Acid; Bone and Bones; Bone Neoplasms; Cell Line, Tumor; Doxorubicin; Drug Carriers; Drug Liberation; Durapatite; Humans; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kinetics; Micelles; Oligopeptides; Osteosarcoma | 2014 |
Engineering a biomimetic three-dimensional nanostructured bone model for breast cancer bone metastasis study.
Topics: Biomimetic Materials; Bone Neoplasms; Breast Neoplasms; Cell Differentiation; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chitosan; Crystallization; Durapatite; Female; Humans; Imaging, Three-Dimensional; Mesenchymal Stem Cells; Microscopy, Electron, Transmission; Models, Biological; Nanostructures; Neoplasm Invasiveness; Osteogenesis; Tissue Engineering; Tissue Scaffolds | 2015 |
Hydroxyapatite-coated collars reduce radiolucent line progression in cemented distal femoral bone tumor implants.
Topics: Adolescent; Adult; Aged; Bone Neoplasms; Chondrosarcoma; Coated Materials, Biocompatible; Durapatite; Female; Femoral Neoplasms; Humans; Male; Middle Aged; Osseointegration; Osteosarcoma; Prostheses and Implants; Prosthesis Failure | 2015 |
Theranostic Applications of Lutetium-177 in Radionuclide Therapy.
Topics: Bone Neoplasms; Durapatite; Half-Life; Humans; Octreotide; Organometallic Compounds; Organophosphorus Compounds; Pain; Radioisotopes; Radiopharmaceuticals; Receptors, Peptide; Theranostic Nanomedicine | 2016 |
[Effect of fluo-hydroxyapatite on biological properies of osteosarcoma MG63 cells].
Topics: Alkaline Phosphatase; Analysis of Variance; Biocompatible Materials; Bone Neoplasms; Cell Differentiation; Cell Proliferation; Collagen Type I; Core Binding Factor Alpha 1 Subunit; Durapatite; Humans; Hydroxyapatites; Osteocalcin; Osteogenesis; Osteosarcoma; Spectroscopy, Fourier Transform Infrared; X-Ray Diffraction | 2015 |
Raman spectroscopy for grading of live osteosarcoma cells.
Topics: Basigin; Bone Neoplasms; Cell Differentiation; Cell Line; Durapatite; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mesenchymal Stem Cells; Neoplasm Grading; Osteoblasts; Osteosarcoma; Real-Time Polymerase Chain Reaction; RNA; Spectrum Analysis, Raman | 2015 |
Selenite-Releasing Bone Mineral Nanoparticles Retard Bone Tumor Growth and Improve Healthy Tissue Functions In Vivo.
Topics: Animals; Biocompatible Materials; Bone Density; Bone Neoplasms; Durapatite; Mice; Mice, Nude; Nanoparticles; Selenious Acid | 2015 |
Preparation and characterization of an iron oxide-hydroxyapatite nanocomposite for potential bone cancer therapy.
Topics: Bone Neoplasms; Calorimetry, Differential Scanning; Cell Death; Cell Line, Tumor; Durapatite; Ferric Compounds; Humans; Magnetometry; Nanocomposites; Spectroscopy, Fourier Transform Infrared; Thermogravimetry | 2015 |
Nano-Hydroxyapatite Doped with Ho-166 as Drug Delivery System for Bone Cancer Therapy and Diagnosis: Developing a Theragnostic Radiopharmaceuticals.
Topics: Animals; Antineoplastic Agents; Bone Neoplasms; Dose-Response Relationship, Drug; Drug Delivery Systems; Drug Screening Assays, Antitumor; Durapatite; Female; Holmium; Male; Molecular Structure; Nanostructures; Radiopharmaceuticals; Rats; Rats, Wistar; Structure-Activity Relationship | 2017 |
Palliative care of bone pain due to skeletal metastases: Exploring newer avenues using neutron activated (45)Ca.
Topics: Animals; Bone Neoplasms; Calcium Chloride; Calcium Radioisotopes; Durapatite; Hydrogen-Ion Concentration; Neutrons; Pain; Pain Management; Palliative Care; Radiochemistry; Rats; Rats, Wistar; Strontium Radioisotopes | 2016 |
Novel (188)Re multi-functional bone-seeking compounds: Synthesis, biological and radiotoxic effects in metastatic breast cancer cells.
Topics: Animals; Biological Transport; Bone Neoplasms; Breast Neoplasms; Cell Line, Tumor; Chemistry Techniques, Synthetic; Durapatite; Female; Mice; Neoplasm Metastasis; Organometallic Compounds; Radioisotopes; Rhenium; Tissue Distribution | 2016 |
Porous nano-hydroxyapatite/collagen scaffold containing drug-loaded ADM-PLGA microspheres for bone cancer treatment.
Topics: Animals; Antibiotics, Antineoplastic; Bone Neoplasms; Cell Line, Tumor; Collagen; Doxorubicin; Durapatite; Female; Humans; Lactic Acid; Male; Mice; Mice, Nude; Nanostructures; Osteosarcoma; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rabbits; Rats; Rats, Sprague-Dawley; Tissue Scaffolds | 2016 |
Spherical porous hydroxyapatite granules containing composites of magnetic and hydroxyapatite nanoparticles for the hyperthermia treatment of bone tumor.
Topics: Bone Neoplasms; Durapatite; Magnetite Nanoparticles; Microscopy, Electron, Transmission; Temperature; X-Ray Diffraction | 2016 |
Monomethyl Auristatin E Phosphate Inhibits Human Prostate Cancer Growth.
Topics: Animals; Antimitotic Agents; Apoptosis; Bone Neoplasms; Calcium; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Disease Models, Animal; Durapatite; Humans; Ions; Male; Mice; Microtubules; Oligopeptides; Phosphates; Prostatic Neoplasms; Tibia; Tubulin Modulators; Tumor Burden; Xenograft Model Antitumor Assays | 2016 |
Improving the degradation behavior and in vitro biological property of nano-hydroxyapatite surface- grafted with the assist of citric acid.
Topics: Biocompatible Materials; Bone Neoplasms; Cell Adhesion; Cell Proliferation; Citric Acid; Durapatite; Humans; Lactic Acid; Nanoparticles; Osteosarcoma; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Tumor Cells, Cultured | 2016 |
Development of a bone-targeted pH-sensitive liposomal formulation containing doxorubicin: physicochemical characterization, cytotoxicity, and biodistribution evaluation in a mouse model of bone metastasis.
Topics: Animals; Antibiotics, Antineoplastic; Bone and Bones; Bone Neoplasms; Buffers; Calorimetry, Differential Scanning; Cell Death; Cell Line, Tumor; Chemical Phenomena; Chemistry, Pharmaceutical; Disease Models, Animal; Doxorubicin; Durapatite; Female; Humans; Hydrogen-Ion Concentration; Mice; Mice, Inbred BALB C; Mice, Nude; Nanostructures; Polyethylene Glycols; Scattering, Small Angle; Serum; Tissue Distribution; X-Ray Diffraction | 2016 |
In Vitro and in Vivo Mechanism of Bone Tumor Inhibition by Selenium-Doped Bone Mineral Nanoparticles.
Topics: Animals; Apoptosis; Bone Neoplasms; Cell Line, Tumor; Durapatite; Nanoparticles; Reactive Oxygen Species; Selenium | 2016 |
Engineered Nanomedicine with Alendronic Acid Corona Improves Targeting to Osteosarcoma.
Topics: Alendronate; Biocompatible Materials; Bone Density Conservation Agents; Bone Neoplasms; Calcium; Cell Separation; Diffusion; Dose-Response Relationship, Drug; Drug Carriers; Drug Delivery Systems; Durapatite; Flow Cytometry; Humans; Inhibitory Concentration 50; Ligands; Lipids; Magnetic Resonance Spectroscopy; Nanomedicine; Nanoparticles; Osteosarcoma; Polyglycolic Acid; Protein Engineering; Spectroscopy, Fourier Transform Infrared | 2016 |
Calcium phosphate nanoparticles functionalized with alendronate-conjugated polyethylene glycol (PEG) for the treatment of bone metastasis.
Topics: Alendronate; Animals; Antimetabolites, Antineoplastic; Bone Neoplasms; Calcium Phosphates; Cell Line; Cell Line, Tumor; Cell Survival; Drug Carriers; Drug Delivery Systems; Durapatite; Female; Humans; Methotrexate; Mice; Nanoparticles; Photoelectron Spectroscopy; Polyethylene Glycols; Rats; Rats, Sprague-Dawley; Tissue Distribution | 2017 |
A novel 3-D mineralized tumor model to study breast cancer bone metastasis.
Topics: Animals; Bone Neoplasms; Breast Neoplasms; Calcification, Physiologic; Cell Adhesion; Cell Line; Cell Line, Tumor; Cell Proliferation; Culture Media, Conditioned; Durapatite; Female; Humans; Imaging, Three-Dimensional; Mice; Microscopy, Electron, Scanning | 2010 |
Synthesis and characterization of collagen/hydroxyapatite: magnetite composite material for bone cancer treatment.
Topics: Bone and Bones; Bone Neoplasms; Bone Transplantation; Calcium Metabolism Disorders; Collagen; Durapatite; Extracellular Matrix; Ferrosoferric Oxide | 2010 |
Radiological and histological analysis of synthetic bone grafts in recurring giant cell tumour of bone: a retrospective study.
Topics: Adult; Apatites; Biocompatible Materials; Bone Neoplasms; Bone Substitutes; Bone Transplantation; Calcium Phosphates; Ceramics; Cohort Studies; Durapatite; Female; Giant Cell Tumor of Bone; Humans; Leg Bones; Male; Neoplasm Recurrence, Local; Radiography; Reoperation; Retrospective Studies; Silicic Acid; Young Adult | 2010 |
Novel fully interconnected porous hydroxyapatite ceramic in surgical treatment of benign bone tumor.
Topics: Adolescent; Adult; Aged; Bone Neoplasms; Bone Substitutes; Ceramics; Child; Child, Preschool; Durapatite; Female; Follow-Up Studies; Humans; Male; Middle Aged; Osteogenesis; Retrospective Studies; Young Adult | 2010 |
Preparation of magnetic and bioactive calcium zinc iron silicon oxide composite for hyperthermia treatment of bone cancer and repair of bone defects.
Topics: Animals; Body Fluids; Bone Diseases; Bone Neoplasms; Calcium; Calorimetry; Cell Survival; Durapatite; Humans; Hyperthermia, Induced; Iron; Magnetics; Osteoblasts; Oxides; Particle Size; Rats; Rats, Sprague-Dawley; Silicon; X-Ray Diffraction; Zinc | 2011 |
Hydroxyapatite nanoparticle-containing scaffolds for the study of breast cancer bone metastasis.
Topics: Bone and Bones; Bone Neoplasms; Breast Neoplasms; Durapatite; Female; Humans; Interleukin-8; Materials Testing; Nanoparticles; Neoplasm Metastasis; Particle Size; Tissue Scaffolds; Tumor Cells, Cultured; X-Ray Diffraction | 2011 |
An injectable calcium phosphate cement for the local delivery of paclitaxel to bone.
Topics: Biological Availability; Bone Cements; Bone Neoplasms; Breast Neoplasms; Calcium Phosphates; Cell Line, Tumor; Cell Survival; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Delivery Systems; Durapatite; Female; Humans; Microscopy, Electron, Scanning; Osteosarcoma; Paclitaxel; Photoelectron Spectroscopy; Porosity; Serum Albumin | 2011 |
Dialkyl bisphosphonate platinum(II) complex as a potential drug for metastatic bone tumor.
Topics: Adsorption; Antineoplastic Agents; Bone Neoplasms; Carboplatin; Cell Line, Tumor; Cisplatin; Coordination Complexes; Diphosphonates; Durapatite; Humans; Neoplasm Metastasis; Osteoclasts; Platinum | 2011 |
Preparation and evaluation of a radiogallium complex-conjugated bisphosphonate as a bone scintigraphy agent.
Topics: Animals; Bone and Bones; Bone Neoplasms; Chelating Agents; Diphosphonates; Drug Stability; Durapatite; Gallium Radioisotopes; Half-Life; Heterocyclic Compounds, 1-Ring; Male; Mice; Organometallic Compounds; Positron-Emission Tomography | 2011 |
Synthesis and evaluation of a novel 68Ga-chelate-conjugated bisphosphonate as a bone-seeking agent for PET imaging.
Topics: Animals; Bone and Bones; Bone Neoplasms; Cell Line, Tumor; Chelating Agents; Diphosphonates; Durapatite; Gallium Radioisotopes; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Male; Mice; Osteolysis; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Rats; Reproducibility of Results | 2011 |
(68)Ga-BPAMD: PET-imaging of bone metastases with a generator based positron emitter.
Topics: Animals; Bone Neoplasms; Cell Line, Tumor; Diphosphonates; Durapatite; Electrons; Gallium Radioisotopes; Heterocyclic Compounds, 1-Ring; Male; Positron-Emission Tomography; Radiochemistry; Rats | 2012 |
[Repairing bone defect with nano-hydroxyapatite and polyamide 66 composite after giant cell tumor operations].
Topics: Adolescent; Adult; Aged; Biocompatible Materials; Bone Neoplasms; Bone Substitutes; Carcinoma, Giant Cell; Durapatite; Female; Femur; Humans; Male; Middle Aged; Nanostructures; Nylons; Orthopedic Procedures; Prosthesis Implantation; Young Adult | 2012 |
Development of novel bisphosphonate prodrugs of doxorubicin for targeting bone metastases that are cleaved pH dependently or by cathepsin B: synthesis, cleavage properties, and binding properties to hydroxyapatite as well as bone matrix.
Topics: Bone and Bones; Bone Neoplasms; Cathepsin B; Diphosphonates; Doxorubicin; Durapatite; Humans; Hydrogen-Ion Concentration; Prodrugs | 2012 |
Selective effects of hydroxyapatite nanoparticles on osteosarcoma cells and osteoblasts.
Topics: Bone Neoplasms; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Durapatite; Humans; Microscopy, Electron, Transmission; Nanoparticles; Organ Specificity; Organelles; Osteoblasts; Osteosarcoma | 2012 |
In vitro studies of human and rat osteoclast activity on hydroxyapatite, beta-tricalcium phosphate, calcium carbonate.
Topics: Adsorption; Adult; Animals; Biocompatible Materials; Bone Neoplasms; Bone Substitutes; Calcium Carbonate; Calcium Phosphates; Cells, Cultured; Ceramics; Durapatite; Female; Giant Cell Tumor of Bone; Humans; Materials Testing; Osteoclasts; Rats; Tibia | 2002 |
Calcium phosphate-chitosan composite scaffolds for bone tissue engineering.
Topics: Alkaline Phosphatase; Biocompatible Materials; Biodegradation, Environmental; Biomarkers; Bone Neoplasms; Bone Substitutes; Cell Culture Techniques; Cell Differentiation; Cell Division; Chitin; Chitosan; Durapatite; Glass; Humans; Isoenzymes; Materials Testing; Microscopy, Electron, Scanning; Neoplasm Proteins; Osteoblasts; Osteocalcin; Osteosarcoma; Solubility; Tissue Engineering; Tumor Cells, Cultured | 2003 |
Tissue response to porous hydroxyapatite ceramic in the human femoral head.
Topics: Biocompatible Materials; Bone Neoplasms; Bone Transplantation; Ceramics; Durapatite; Female; Femur Head; Giant Cell Tumor of Bone; Humans; Middle Aged; Porosity | 2003 |
[QUANTITATIVE OBSERVATION OF THE COURSE OF CALCIUM CHANGES IN BONE BY MEANS OF ROENTGENOLOGIC SUBSTANCE ANALYSIS].
Topics: Adrenal Cortex Hormones; Anabolic Agents; Bone and Bones; Bone Diseases; Bone Neoplasms; Calcium; Durapatite; Fractures, Bone; Humans; Neoplasm Metastasis; Phosphorus; Steroids; Technology, Radiologic | 1964 |
Calcium hydroxyapatite ceramic implants in bone tumour surgery. A long-term follow-up study.
Topics: Adolescent; Adult; Biocompatible Materials; Bone Neoplasms; Bone Substitutes; Child; Child, Preschool; Curettage; Durapatite; Female; Follow-Up Studies; Fractures, Bone; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Osseointegration; Postoperative Complications; Radiography; Retrospective Studies | 2004 |
Improvement in biocompatibility of ZrO2-Al2O3 nano-composite by addition of HA.
Topics: Alkaline Phosphatase; Aluminum Oxide; Biocompatible Materials; Bone Neoplasms; Cell Differentiation; Cell Division; Cell Line, Tumor; Durapatite; Humans; Materials Testing; Nanostructures; Neoplasm Proteins; Osteoblasts; Osteosarcoma; Powders; Weight-Bearing; Zirconium | 2005 |
Hydroxyapatite and fluor-hydroxyapatite layered film on titanium processed by a sol-gel route for hard-tissue implants.
Topics: Biocompatible Materials; Bone Neoplasms; Cell Adhesion; Cell Differentiation; Cell Division; Cell Line, Tumor; Durapatite; Gels; Humans; Materials Testing; Microscopy, Electron, Scanning; Osteosarcoma; Phase Transition; Prostheses and Implants; Titanium | 2004 |
Tissue engineering approach to the treatment of bone tumors: three cases of cultured bone grafts derived from patients' mesenchymal stem cells.
Topics: Adolescent; Biocompatible Materials; Bone Matrix; Bone Neoplasms; Cell Differentiation; Cell Proliferation; Child; Durapatite; Female; Follow-Up Studies; Humans; Male; Mesenchymal Stem Cells; Middle Aged; Osteoblasts; Tissue Engineering; Treatment Outcome | 2006 |
The application of a murine bone bioreactor as a model of tumor: bone interaction.
Topics: Animals; Bioreactors; Bone Development; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Neoplasms; Cell Line, Tumor; Disease Models, Animal; Durapatite; Female; Mammary Neoplasms, Experimental; Mice; Tissue Engineering; Transforming Growth Factor beta | 2006 |
Epiphyseal preservation and an intercalary vascularized fibular graft with hydroxyapatite composites. Reconstruction in metaphyseal osteosarcoma of the proximal tibia: a case report.
Topics: Adolescent; Bone Neoplasms; Durapatite; Epiphyses; Fibula; Humans; Male; Osteosarcoma; Osteotomy; Tibia; Transplantation, Autologous | 2008 |
Use of a novel bone graft substitute in peri-articular bone tumours of the knee.
Topics: Adult; Bone Cysts, Aneurysmal; Bone Neoplasms; Bone Substitutes; Calcium Sulfate; Child; Durapatite; Female; Femur; Follow-Up Studies; Giant Cell Tumor of Bone; Humans; Male; Middle Aged; Tibia; Treatment Outcome | 2007 |
188Re-labelled gemcitabine/bisphosphonate (Gem/BP): a multi-functional, bone-specific agent as a potential treatment for bone metastases.
Topics: Animals; Bone and Bones; Bone Neoplasms; Cattle; Combined Modality Therapy; Deoxycytidine; Diphosphonates; Durapatite; Etidronic Acid; Female; Gemcitabine; Humans; In Vitro Techniques; Mice; Mice, Inbred BALB C; Organometallic Compounds; Radioisotopes; Radiopharmaceuticals; Rhenium; Tissue Distribution | 2008 |
Composite ceramic bone graft substitute in the treatment of locally aggressive benign bone tumours.
Topics: Adolescent; Adult; Bone Cysts, Aneurysmal; Bone Neoplasms; Bone Substitutes; Ceramics; Child; Durapatite; Female; Femoral Neoplasms; Giant Cell Tumor of Bone; Humans; Male; Middle Aged; Tibia | 2008 |
Anticancer effects of adriamycin-loaded hydroxyapatite implants determined in a Swarm rat chondrosarcoma model.
Topics: Animals; Bone Neoplasms; Chondrosarcoma; Delayed-Action Preparations; Disease Models, Animal; Doxorubicin; Drug Delivery Systems; Durapatite; Female; Life Expectancy; Male; Prostheses and Implants; Rats; Rats, Sprague-Dawley | 1994 |
[Filling up small bone defects with bone ceramics (hydroxylapatite)].
Topics: Adult; Aged; Aged, 80 and over; Bone Cysts; Bone Neoplasms; Durapatite; Female; Hand; Humans; Hydroxyapatites; Male; Middle Aged; Osseointegration; Postoperative Complications; Radiography | 1993 |
Comparison of the release of growth hormone from hydroxyapatite, heat-treated hydroxyapatite, and fluoroapatite coatings on titanium.
Topics: Apatites; Biocompatible Materials; Bone Neoplasms; Cell Division; Ceramics; DNA; Durapatite; Enzyme-Linked Immunosorbent Assay; Growth Hormone; Hot Temperature; Humans; Microscopy, Electron, Scanning; Osteoblasts; Osteosarcoma; Thymidine; Titanium; Tumor Cells, Cultured | 1995 |
Radiation dosimetry in human bone using electron paramagnetic resonance.
Topics: Biophysical Phenomena; Biophysics; Bone and Bones; Bone Neoplasms; Collagen; Durapatite; Electron Spin Resonance Spectroscopy; Electrons; Humans; In Vitro Techniques; Minerals; Radiometry; Radiotherapy Dosage | 1995 |
Sustained release of adriamycin from implanted hydroxyapatite blocks for the treatment of experimental osteogenic sarcoma in mice.
Topics: Animals; Antibiotics, Antineoplastic; Bone Neoplasms; Delayed-Action Preparations; Doxorubicin; Drug Implants; Durapatite; Mice; Osteosarcoma; Sarcoma, Experimental | 1996 |
Tumoral calcinosis of the triangular fibrocartilage complex: a case report.
Topics: Adult; Bone Neoplasms; Calcinosis; Carpal Bones; Cartilage, Articular; Diagnosis, Differential; Diagnostic Techniques, Surgical; Durapatite; Female; Fibrosis; Foreign-Body Reaction; Giant Cells, Foreign-Body; Humans; Magnetic Resonance Imaging; Metaplasia; Synovial Membrane | 1997 |
[Bone regeneration stimulated by bone substitute materials].
Topics: Bone Demineralization, Pathologic; Bone Neoplasms; Bone Regeneration; Bone Substitutes; Bone Transplantation; Ceramics; Durapatite; Fractures, Bone; Humans; Transplantation, Autologous; Transplantation, Heterologous | 1998 |
Synthesis and preclinical pharmacology of 2-(2-aminopyrimidinio) ethylidene-1,1-bisphosphonic acid betaine (ISA-13-1)-a novel bisphosphonate.
Topics: Administration, Oral; Alendronate; Animals; Antineoplastic Agents; Betaine; Bone Diseases; Bone Neoplasms; Calcium; Capsules; Carcinoma 256, Walker; Cell Line; Diphosphonates; Diuretics, Osmotic; Durapatite; Injections, Intravenous; Intestinal Absorption; Macrophages; Male; Mannitol; Osteogenesis; Pamidronate; Rats; Rats, Inbred Strains; Tight Junctions; Tissue Distribution | 1999 |
[The use of ceramics in osteoplastic operations in onco-orthopedics].
Topics: Adolescent; Adult; Biocompatible Materials; Bone and Bones; Bone Neoplasms; Ceramics; Child; Durapatite; Female; Humans; Male; Middle Aged; Postoperative Period; Prostheses and Implants; Radiography; Treatment Outcome | 1999 |
Cementless fixation for primary segmental bone tumor endoprostheses.
Topics: Bone and Bones; Bone Neoplasms; Child; Coated Materials, Biocompatible; Computer Simulation; Durapatite; Femoral Neoplasms; Finite Element Analysis; Humans; Humerus; Osseointegration; Prosthesis Design; Prosthesis Implantation; Radiography; Reoperation; Stress, Mechanical; Tibia; Titanium | 2000 |
[Patient medical rehabilitation following osteoplastic operations using hydroxylapatite-based porous ceramic].
Topics: Adolescent; Adult; Bone and Bones; Bone Neoplasms; Bone Substitutes; Ceramics; Child; Durapatite; Humans; Immobilization; Middle Aged; Postoperative Care; Surgical Procedures, Operative; Time Factors | 1999 |
The use of an in situ curing hydroxyapatite cement as an alternative to bone graft following removal of enchondroma of the hand.
Topics: Adult; Biocompatible Materials; Bone Cements; Bone Neoplasms; Chondroma; Durapatite; Female; Fingers; Humans; Male; Middle Aged; Radiography | 2000 |
Use of hydroxyapatite to fill cavities after excision of benign bone tumours. Clinical results.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biocompatible Materials; Bone Neoplasms; Child; Child, Preschool; Curettage; Durapatite; Female; Follow-Up Studies; Fractures, Spontaneous; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Osseointegration; Osteotomy; Pain, Postoperative; Splints; Tomography, X-Ray Computed; Treatment Outcome | 2000 |
Bone metastatic LNCaP-derivative C4-2B prostate cancer cell line mineralizes in vitro.
Topics: Anthraquinones; Bone Morphogenetic Protein 7; Bone Morphogenetic Proteins; Bone Neoplasms; Calcinosis; Calcium; Cell Division; Core Binding Factor Alpha 1 Subunit; Durapatite; Gene Expression Regulation, Neoplastic; Glycoproteins; Humans; Male; Neoplasm Proteins; Osteoblasts; Osteoprotegerin; Prostatic Neoplasms; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; Spectrophotometry, Infrared; Spectrum Analysis, Raman; Staining and Labeling; Transcription Factors; Transforming Growth Factor beta; Tumor Cells, Cultured | 2001 |
Spongy hydroxyapatite in hand surgery--a five year follow-up.
Topics: Adult; Aged; Aged, 80 and over; Biocompatible Materials; Bone Neoplasms; Chondroma; Cysts; Durapatite; Female; Fingers; Follow-Up Studies; Hand; Humans; Male; Middle Aged; Treatment Outcome | 2002 |
Slow release of anticancer drugs from porous calcium hydroxyapatite ceramic.
Topics: Animals; Antineoplastic Agents; Bone Neoplasms; Ceramics; Cisplatin; Delayed-Action Preparations; Drug Implants; Durapatite; Hydroxyapatites; Injections, Intraperitoneal; Mice; Mice, Inbred C3H; Osteosarcoma; Rats; Rats, Inbred Strains | 1992 |
[Application of a slow release system of anti-cancer drug retained in calcium hydroxyapatite ceramic against experimental bone and soft tissue sarcoma].
Topics: Animals; Bone Neoplasms; Cisplatin; Delayed-Action Preparations; Durapatite; Female; Hydroxyapatites; Injections, Intraperitoneal; Mice; Mice, Inbred C3H; Rats; Rats, Inbred Strains; Soft Tissue Neoplasms | 1991 |
The use of calcium hydroxyapatite ceramic in bone tumour surgery.
Topics: Adolescent; Adult; Aged; Bone and Bones; Bone Neoplasms; Ceramics; Child; Durapatite; Humans; Hydroxyapatites; Methods; Middle Aged; Postoperative Complications; Prostheses and Implants; Radiography | 1990 |
Dacron fabric-enveloped hydroxyapatite prosthesis for sternal tumor defect: an autopsy report.
Topics: Adult; Bone Neoplasms; Durapatite; Female; Humans; Hydroxyapatites; Manubrium; Plasmacytoma; Polyethylene Terephthalates; Prostheses and Implants; Sternum; Thoracic Surgery | 1990 |
Hydroxyapatite ceramic as a bone substitute.
Topics: Adolescent; Adult; Biocompatible Materials; Bone Diseases; Bone Neoplasms; Ceramics; Child; Durapatite; Female; Follow-Up Studies; Fractures, Ununited; Humans; Hydroxyapatites; Male; Middle Aged; Prostheses and Implants; Scoliosis; Spinal Fusion | 1990 |